玻璃酸酶治疗青光眼术后高眼压疗效观察  

Observation on the Effect of Hyaluronidase in Treating Intraocular Hypertension after Glaucoma Surgery

作　　者：蓝桂英[1] 杨国华[1] 庄小平[1] 徐岩[1] 郭珠娥 

机构地区：[1]河南省眼科研究所,郑州450003

出　　处：《眼科研究》1992年第1期40-42,共3页Chinese Ophthalmic Research

摘　　要：以玻璃酸酶结膜下注射,治疗各类青光眼术后高眼压,共68例84眼;随访3个月～7年,平均观察2年零6个月。近期疗效明显,有效率达82%,远期疗效76.4%,术后高眼压在一个月以内者,注射效果较为满意。68 cases (84 eyes)of intraocular hypertenion pressure after glaucoma surgery weretreated by hyaluronidase subconjunctival injection.They were followed up for 3 months～7years.The average time was 2 years and a half.The short term effective rate was 82%,and the long-term effective rate 61%.Satisfactory results were obtained,especially withinone month after surgery.

关 键 词：玻璃酸酶 青光眼 术后 高眼压 

分 类 号：R775.05[医药卫生—眼科]